Any improvement in GFR will increase ACE inhibitor renal clearance (if the ACE inhibitor is one that is renally cleared) and in so doing do away with the original basis for the hypotension.

Routine use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is recommended in proteinuric nontransplant kidney disease patients, to reduce proteinuria and ...

Inhibition of the renin–angiotensin system using either an angiotensin-converting-enzyme (ACE) inhibitor or an angiotensin-receptor blocker (ARB) effectively decreases rates of urinary protein ...

We considered two treatment strategies. In the ACE inhibitor treatment strategy, patients are treated with benazepril 10 mg twice a day. Patients in the control group receive no ACE inhibitor.

Researchers continue to investigate ACE inhibitor use in treating liver disease, uterine fibroids, and more. ACE inhibitors were approved for treating hypertension in 1981. Over time, ACE ...